CoolSculpting®

CoolSculpting® is the world's #1 non-invasive fat reduction technology with over 8 million treatments performed* in over 5000 clinics across 74 countries†. The procedure aims to help you contour your body by freezing away stubborn pockets of superficial fat in targeted areas. There are no needles or surgery involved. Thetechnology was developed by Harvard scientists and is backed by over 20 years of research.



CoolSculpting® works by selectively freezing and subsequently damaging the fat cells under the skin whilst preserving the skin and surrounding areas‡. Thesecrystallised fat cells die and are naturally eliminated from the body‡. You can start to see results at 6 weeks and should see final results around 12 weeks aftertreatment. Commonly treated areas are the abdomen, flanks (love handles), inner and outer thighs, under the buttocks, upper arms and under the chin.

Please be advised that Allergan Aesthetics will no longer be selling the CoolSculpting® device and consumables in Australia and New Zealand as of December 2027. If you have any questions or require further information, please contact your CoolSculpting representative or the Allergan Aesthetics Customer Service team.

For more information on CoolSculpting® visit

To find your nearest CoolSculpting® clinic for a complimentary consultation, please visit

*As of January 2025
†As of September 2018
‡Data obtained from cryolipolysis investigations using a porcine model.

 

THIS PRODUCT MAY NOT BE RIGHT FOR YOU. READ THE WARNINGS BEFORE PURCHASE. WARNINGS CAN BE FOUND BY ASKING YOUR HEALTH PROFESSIONAL FOR THE INSTRUCTIONS FOR USE.

FOLLOW THE INSTRUCTIONS FOR USE. IF SYMPTOMS PERSIST TALK TO YOUR HEALTH PROFESSIONAL. A HEALTHY DIET AND EXERCISE IS IMPORTANT.

COOLSCULPTING® IS NOT A WEIGHT LOSS PROCEDURE AND SHOULD NOT REPLACE A HEALTHY DIET AND ACTIVE LIFESTYLE. 

DIET AND EXERCISE REMAINS THE MAINSTAY OF WEIGHT LOSS.

CoolSculpting® and its design are registered trademarks of ZELTIQ Aesthetics, Inc., an Allergan affiliate.  

COOLSCULPTING® is not listed on the New Zealand Pharmaceutical Schedule - patient charges for the medical device and healthcare professional fees apply.

This Medical Device must be applied by a healthcare professional.

Patients should not have the CoolSculpting® procedure if they suffer from cryoglobulinaemia, cold agglutinin disease or paroxysmal cold haemoglobinuria. Be careful using CoolSculpting® in pregnant or breastfeeding women, in patients who are sensitive to cold or to fructose, glycerin, isopropyl alcohol or propylene glycol; in patients with poor circulation, recent surgery, scar tissue, skin conditions such as eczema, dermatitis, or rashes in the area to be treated, nerve pain following shingles, nerve damage due to diabetes, poor skin sensation, open or infected wounds, bleeding disorders or use of blood thinners, hernia in or near the area to be treated; and in patientswith implanted pacemakers and defibrillators.

 

 

 

 

NZ-AGNA-250009 V1 | DoP: May 2025